(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | (FY)Mar 31, 2022 | (Q4)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 14.87%-906.66K | 94.02%-8.73K | -4.87%-573.41K | -6.42%-1.07M | -132.06%-145.97K | 12.80%-546.79K | 62.98%-50.42K | 53.54%-321.87K | -16.61%-1M | 459.76%455.26K |
Net income from continuing operations | 44.58%-3.3M | -116.98%-1.03M | -128.18%-171.58K | -441.11%-5.95M | 58.20%-473.58K | -102.06%-75.2K | 81.65%-781.45K | -821.62%-4.62M | -109.78%-1.1M | -124.03%-1.13M |
Operating gains losses | -49.10%1.08M | -30.70%69.77K | -73.70%226.65K | 806.10%2.12M | 149.99%100.68K | 838.82%861.65K | 3,741.18%782.24K | 323.04%378.08K | 90.09%-300.62K | 90.71%-201.4K |
Depreciation and amortization | ---- | ---- | -1,451.19%-61.78K | ---- | ---- | ---3.98K | ---- | ---- | --0 | --0 |
Asset impairment expenditure | --229.93K | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
Unrealized gains and losses of investment securities | -85.46%493.37K | -84.70%104.26K | 63.49%-360.68K | 547.12%3.39M | -18.56%681.58K | 75.36%-988K | -108.91%-279.34K | 651.41%3.98M | 92.87%-758.69K | 125.05%836.94K |
Remuneration paid in stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -10.08%905.15K | --0 |
Deferred tax | --0 | ---- | ---- | -372.09%-585K | ---- | ---- | ---- | ---- | -41.89%215K | ---- |
Other non cashItems | 1,367.12%93.11K | ---- | ---- | ---7.35K | ---- | ---- | ---- | ---- | ---- | ---- |
Change In working capital | 1,592.75%496.49K | 238.54%452.65K | 39.63%-206.01K | -185.85%-33.26K | -81.87%133.71K | 4.93%-341.26K | 121.83%228.14K | 87.84%-53.84K | -46.69%38.74K | 149.64%737.57K |
-Change in receivables | -221.78%-83.64K | 80.47%-23.69K | -24,811.03%-131.03K | 138.80%68.68K | -189.29%-121.32K | 99.60%-526 | 284.35%252.72K | -45.80%-62.2K | -1,628.62%-177.03K | -34.25%135.87K |
-Change in prepaid assets | -180.26%-24.62K | 552.76%65.25K | -2,068.15%-90K | -59.93%30.67K | -98.00%10K | 98.95%-4.15K | -90.74%24.35K | 100.16%476 | 182.08%76.53K | 565.67%500.28K |
-Change in payables and accrued expense | 540.60%606.5K | 69.93%407.81K | 107.24%24.37K | -165.25%-137.66K | 16.95%239.99K | -311.43%-336.58K | 164.40%75.6K | -223.82%-116.66K | 155.46%210.98K | 64.84%205.21K |
-Change in other current liabilities | -134.83%-1.76K | -34.83%3.29K | ---9.35K | 107.03%5.04K | 104.86%5.04K | --0 | -232.04%-124.54K | 273.60%124.54K | -200.00%-71.74K | ---103.78K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 14.87%-906.66K | 94.02%-8.73K | -4.87%-573.41K | -6.42%-1.07M | -132.06%-145.97K | 12.80%-546.79K | 62.98%-50.42K | 53.54%-321.87K | -16.61%-1M | 459.76%455.26K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 141.43%235.27K | -20.14%11.37K | 45.68%-449.55K | -102.42%-567.87K | -97.93%14.24K | -186.14%-827.62K | 112.24%275.26K | -109.31%-29.74K | -1,245.55%-280.55K | 230.08%688.35K |
Net PPE purchase and sale | 63.03%-891.95K | 62.92%-91.51K | 40.87%-653.22K | 49.19%-2.41M | 85.85%-246.77K | 6.58%-1.1M | 64.61%-568.88K | -128.73%-492.49K | -760.81%-4.75M | -299.97%-1.74M |
Net investment purchase and sale | -66.00%627.21K | -60.58%102.88K | -26.48%203.67K | -58.71%1.84M | -89.27%261.01K | -87.07%277.04K | 231.56%844.14K | -13.48%462.75K | 675.53%4.47M | 2,708.65%2.43M |
Net other investing changes | --500K | --0 | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 141.43%235.27K | -20.14%11.37K | 45.68%-449.55K | -102.42%-567.87K | -97.93%14.24K | -186.14%-827.62K | 112.24%275.26K | -109.31%-29.74K | -1,245.55%-280.55K | 230.08%688.35K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -46.70%667.6K | -182.82%-97.91K | -19.46%1.11M | -23.88%1.25M | 114.19%118.23K | 495.01%1.38M | 79.21%-229.54K | -100.49%-19.33K | 92.69%1.65M | -227.49%-833.25K |
Net common stock issuance | -24.82%1.22M | --0 | -17.13%1.35M | -22.43%1.63M | --0 | 1,656.31%1.63M | --0 | --0 | 125.21%2.1M | ---668.1K |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | -62.96%70K | --0 |
Net other financing activities | -48.02%-557.17K | -182.82%-97.91K | 3.99%-235.96K | 28.22%-376.42K | 171.59%118.23K | -0.11%-245.77K | -492.53%-229.54K | 74.23%-19.33K | -96.09%-524.41K | 52.19%-165.15K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -46.70%667.6K | -182.82%-97.91K | -19.46%1.11M | -23.88%1.25M | 114.19%118.23K | 495.01%1.38M | 79.21%-229.54K | -100.49%-19.33K | 92.69%1.65M | -227.49%-833.25K |
Net cash flow | ||||||||||
Beginning cash position | -98.63%5.28K | 415.04%96.75K | -42.85%5.67K | 1,718.96%385.57K | -75.03%18.79K | -89.17%9.92K | -99.59%14.62K | 1,718.96%385.57K | 2,234.47%21.2K | -91.92%75.22K |
Current changes in cash | 99.00%-3.79K | -605.17%-95.27K | 927.09%91.08K | -204.37%-380.29K | -104.35%-13.51K | 154.17%8.87K | 99.87%-4.71K | -110.42%-370.94K | 1,695.89%364.37K | 134.10%310.35K |
End cash Position | -71.92%1.48K | -71.92%1.48K | 415.04%96.75K | -98.63%5.28K | -98.63%5.28K | -75.03%18.79K | -89.17%9.92K | -99.59%14.62K | 1,718.96%385.57K | 1,718.96%385.57K |
Free cash from | 48.28%-1.8M | 74.48%-100.24K | 25.72%-1.23M | 39.51%-3.48M | 69.52%-392.75K | 8.73%-1.65M | 64.48%-619.31K | 10.33%-814.36K | -307.80%-5.75M | -129.06%-1.29M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.